These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34618462)

  • 1. Salivary Metabolomics Reveals that Metabolic Alterations Precede the Onset of Schizophrenia.
    Cui G; Qing Y; Li M; Sun L; Zhang J; Feng L; Li J; Chen T; Wang J; Wan C
    J Proteome Res; 2021 Nov; 20(11):5010-5023. PubMed ID: 34618462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary microbiome profiling reveals a dysbiotic schizophrenia-associated microbiota.
    Qing Y; Xu L; Cui G; Sun L; Hu X; Yang X; Jiang J; Zhang J; Zhang T; Wang T; He L; Wang J; Wan C
    NPJ Schizophr; 2021 Oct; 7(1):51. PubMed ID: 34711862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma metabolic alterations and potential biomarkers in individuals at clinical high risk for psychosis.
    Li Z; Zhang T; Xu L; Wei Y; Cui H; Tang Y; Liu X; Qian Z; Zhang H; Liu P; Li C; Wang J
    Schizophr Res; 2022 Jan; 239():19-28. PubMed ID: 34800912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets?].
    Frajerman A; Kebir O; Chaumette B; Tessier C; Lamazière A; Nuss P; Krebs MO
    Encephale; 2020 Jun; 46(3):209-216. PubMed ID: 32151446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Metabolomic Profiling Based on Fourier Transform-Ion Cyclotron Resonance-Mass Spectrometry: Do the Dysfunctions of Metabolic Pathways Reveal a Universal Risk of Oxidative Stress in Schizophrenia?
    Cui G; Qing Y; Hu X; Wang P; Sun L; Yang X; Jiang J; Zhang J; Wang H; Feng L; Shen Y; Qin S; Wan C
    Antioxid Redox Signal; 2020 Oct; 33(10):679-688. PubMed ID: 32578452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced frontal glutamate + glutamine and N-acetylaspartate levels in patients with chronic schizophrenia but not in those at clinical high risk for psychosis or with first-episode schizophrenia.
    Natsubori T; Inoue H; Abe O; Takano Y; Iwashiro N; Aoki Y; Koike S; Yahata N; Katsura M; Gonoi W; Sasaki H; Takao H; Kasai K; Yamasue H
    Schizophr Bull; 2014 Sep; 40(5):1128-39. PubMed ID: 24023251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Searching for biomarkers in schizophrenia and psychosis: Case-control study using capillary electrophoresis and liquid chromatography time-of-flight mass spectrometry and systematic review for biofluid metabolites.
    Kim S; Okazaki S; Otsuka I; Shinko Y; Horai T; Shimmyo N; Hirata T; Yamaki N; Tanifuji T; Boku S; Sora I; Hishimoto A
    Neuropsychopharmacol Rep; 2022 Mar; 42(1):42-51. PubMed ID: 34889082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
    Wu N; Wang W; Yi M; Cheng S; Wang D
    Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Relationship between the Level of Anterior Cingulate Cortex Metabolites, Brain-Periphery Redox Imbalance, and the Clinical State of Patients with Schizophrenia and Personality Disorders.
    Bryll A; Krzyściak W; Karcz P; Śmierciak N; Kozicz T; Skrzypek J; Szwajca M; Pilecki M; Popiela TJ
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32899276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platform for systems medicine research and diagnostic applications in psychotic disorders-The METSY project.
    Frank E; Maier D; Pajula J; Suvitaival T; Borgan F; Butz-Ostendorf M; Fischer A; Hietala J; Howes O; Hyötyläinen T; Janssen J; Laurikainen H; Moreno C; Suvisaari J; Van Gils M; Orešič M
    Eur Psychiatry; 2018 Apr; 50():40-46. PubMed ID: 29361398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Stress and psychotic transition: A literature review].
    Chaumette B; Kebir O; Mam Lam Fook C; Bourgin J; Godsil BP; Gaillard R; Jay TM; Krebs MO
    Encephale; 2016 Aug; 42(4):367-73. PubMed ID: 27161263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic Connections between Schizophrenia, Antipsychotic Drugs and Metabolic Syndrome: A Variety of Players.
    Molina JD; Avila S; Rubio G; López-Muñoz F
    Curr Pharm Des; 2021; 27(39):4049-4061. PubMed ID: 34348619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salivary cortisol in early psychosis: New findings and meta-analysis.
    Chaumette B; Kebir O; Mam-Lam-Fook C; Morvan Y; Bourgin J; Godsil BP; Plaze M; Gaillard R; Jay TM; Krebs MO
    Psychoneuroendocrinology; 2016 Jan; 63():262-70. PubMed ID: 26520686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency and pattern of childhood symptom onset reported by first episode schizophrenia and clinical high risk youth.
    Woodberry KA; Serur RA; Hallinan SB; Mesholam-Gately RI; Giuliano AJ; Wojcik JD; Keshavan MS; Frazier JA; Goldstein JM; Shenton ME; McCarley RW; Seidman LJ
    Schizophr Res; 2014 Sep; 158(1-3):45-51. PubMed ID: 24924404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?
    Khoury R; Nasrallah HA
    Schizophr Res; 2018 Sep; 199():31-38. PubMed ID: 29703661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells.
    Liu ML; Zheng P; Liu Z; Xu Y; Mu J; Guo J; Huang T; Meng HQ; Xie P
    Mol Biosyst; 2014 Jul; 10(9):2398-406. PubMed ID: 24975926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early auditory gamma-band responses in patients at clinical high risk for schizophrenia.
    Perez VB; Roach BJ; Woods SW; Srihari VH; McGlashan TH; Ford JM; Mathalon DH
    Suppl Clin Neurophysiol; 2013; 62():147-62. PubMed ID: 24053038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
    Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
    Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cognitive deficits in first episode psychosis patients and people at risk for psychosis: from diagnosis to treatment].
    Lecardeur L; Meunier-Cussac S; Dollfus S
    Encephale; 2013 May; 39 Suppl 1():S64-71. PubMed ID: 23528322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe disturbance of glucose metabolism in peripheral blood mononuclear cells of schizophrenia patients: a targeted metabolomic study.
    Liu ML; Zhang XT; Du XY; Fang Z; Liu Z; Xu Y; Zheng P; Xu XJ; Cheng PF; Huang T; Bai SJ; Zhao LB; Qi ZG; Shao WH; Xie P
    J Transl Med; 2015 Jul; 13():226. PubMed ID: 26169624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.